Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 38
Keywords: Biomarkers
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Subject Area:
Article Collection: Enhancing Ethnocultural Diversity and Under-Represented Groups in Dementia Research
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Lucas Nogueira de Carvalho Pelegrini, Vanessa Alexandre da Silva, Marina Mantellatto Grigoli, Izabela Pereira Vatanabe, Patricia Regina Manzine, Marcia Regina Cominetti
Dement Geriatr Cogn Disord (2024) 53 (3): 153–161.
Published Online: 18 April 2024
... ADAM10 plays a central role in AD pathology, attenuating the formation of beta-amyloid peptides and, therefore, their aggregation into senile plaques. This study seeks to investigate ADAM10 as a blood-based biomarker in mild cognitive impairment (MCI) and AD in a diverse group of community-dwelling older...
Journal Articles
Subject Area:
Karger e-Journal Backfile Collection 2023
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Nilton Custodio, Marco Malaga, Rosa Montesinos, Diego Chambergo-Michilot, Fiorella Baca, Juan Carlos Carbajal, Jose Carlos Huilca, Eder Herrera-Perez, David Lira, Monica M. Diaz, Serggio Lanata
Dement Geriatr Cogn Disord (2023) 52 (5-6): 309–317.
Published Online: 12 October 2023
... of AD in early stages of illness (mild cognitive impairment [MCI], early dementia) becomes increasingly important. Biomarkers for AD in low- and middle-income countries (LMICs) are costly and not widely available; hence, it is important to identify cognitive tests that correlate well with AD biomarker...
Journal Articles
Natalia P. Rocha, Antonio L. Teixeira, Gabriela D. Colpo, Michelle A. Babicz, Jennifer L. Thompson, Steven Paul Woods
Dement Geriatr Cogn Disord (2022) 51 (6): 467–474.
Published Online: 28 February 2023
..., and identifying reliable biomarkers has been challenging. Methods: This study included 132 participants aged 50 and older from greater San Diego County. The participants were divided into three groups: PLWH with HAND ( n = 29), PLWH without HAND ( n = 73), and seronegatives without cognitive impairment ( n = 30...
Journal Articles
Dement Geriatr Cogn Disord (2022) 51 (6): 449–459.
Published Online: 28 February 2023
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Delirium Insulin-like growth factor 1 Pathophysiology Biomarkers Systematic review Meta-analysis Delirium is a neuropsychiatric...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Michelle Gerards, Ann-Katrin Schild, Dix Meiberth, Ayda Rostamzadeh, Jörg Janne Vehreschild, Sebastian Wingen-Heimann, Wibke Johannis, Pamela Martino Adami, Oezguer A. Onur, Alfredo Ramirez, Thomas K. Karikari, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Franziska Maier, Frank Jessen
Dement Geriatr Cogn Disord (2022) 51 (2): 182–192.
Published Online: 03 May 2022
... Introduction: Several recent research studies show high performance of blood biomarkers to identify Alzheimer’s disease also in the pre-dementia mild cognitive impairment (MCI) stage, but data from the routine clinical care memory clinic setting are needed. Methods: We examined plasma samples of 144 memory...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Kevin Duff, Laura Wan, Deborah A. Levine, Bruno Giordani, Nicole R. Fowler, Angela Fagerlin, Jace B. King, John M. Hoffman
Dement Geriatr Cogn Disord (2022) 51 (3): 214–220.
Published Online: 27 April 2022
... in patients with Alzheimer’s disease (AD). However, no studies have examined its relationship with AD-related biomarkers. Methods: One-hundred twenty-one older adults (intact, amnestic mild cognitive impairment, mild AD) completed the QDRS, and three biomarkers (amyloid deposition via positron emission...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Theofanis Tsevis, Eric Westman, Konstantinos Poulakis, Olof Lindberg, Atef Badji, Dorota Religa, Lars-Olof Wahlund
Dement Geriatr Cogn Disord (2021) 50 (5): 491–497.
Published Online: 16 November 2021
... to in the content or advertisements. Alcoholic dementia Biomarkers Cognitive assessment Mild cognitive impairment Long-term and extensive alcohol consumption can lead to reduced cognitive performance [1, 2] and is identified as one of the most important risk factors for dementia [3-5...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Article Collection: 30 Years of Dementia and Geriatric Cognitive Disorders
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Dement Geriatr Cogn Disord (2020) 49 (1): 22–37.
Published Online: 08 June 2020
..., instructions or products referred to in the content or advertisements. 2020 Alzheimer’s disease Clinical trials Drug development Translational scoring Biomarkers Target product profile Toxicity Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with cognitive, functional...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Ione O.C. Woollacott, Jennifer M. Nicholas, Carolin Heller, Martha S. Foiani, Katrina M. Moore, Lucy L. Russell, Ross W. Paterson, Ashvini Keshavan, Jonathan M. Schott, Jason D. Warren, Amanda Heslegrave, Henrik Zetterberg, Jonathan D. Rohrer
Dement Geriatr Cogn Disord (2020) 49 (1): 56–76.
Published Online: 28 April 2020
... differed between FTD patients and controls, across different clinical and genetic subtypes of FTD, and between individuals with a clinical FTD syndrome due to AD versus non-AD (frontotemporal lobar degeneration, FTLD) pathology (based on CSF neurodegenerative biomarkers). Eighteen healthy controls and 64...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
Yu Taniguchi, Akihiko Kitamura, Sho Kaito, Yuri Yokoyama, Isao Yokota, Tomohiro Shinozaki, Satoshi Seino, Hiroshi Murayama, Yutaka Matsuyama, Tomoko Ikeuchi, Yoshinori Fujiwara, Shoji Shinkai
Dement Geriatr Cogn Disord (2019) 47 (4-6): 233–242.
Published Online: 17 July 2019
... identified several risk factors for dementia and cognitive decline – the prodromal stage of dementia, and nutritional biomarkers, especially serum albumin and hemoglobin levels, are good predictors of cognitive deterioration. In longitudinal studies, Ng et al. [ 1 ] reported that low albumin levels were...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Geriatrics and Gerontology
,
Neurology and Neuroscience
,
Psychiatry and Psychology
George P. Paraskevas, Anastasia Bougea, Vasilios C. Constantinides, Mara Bourbouli, Olga Petropoulou, Elisabeth Kapaki
Dement Geriatr Cogn Disord (2019) 47 (4-6): 289–296.
Published Online: 16 July 2019
... ELISAs (Innotest; Fujirebio, Gent, Belgium) were used for measurements. Results: According to the current cutoff values of our laboratory, 4 biomarker profiles were noted: abnormal levels of Aβ 42 only (44.7%), full AD profile (39.5%), abnormal levels of τ T only (5.3%), and normal levels of all 3...
Journal Articles
Dement Geriatr Cogn Disord (2018) 46 (3-4): 154–167.
Published Online: 10 September 2018
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Amyloid Alzheimer’s disease Biomarkers Dementia Mild cognitive...
Journal Articles
Dement Geriatr Cogn Disord (2017) 44 (1-2): 45–54.
Published Online: 05 July 2017
... to similar underlying mechanisms. Methods: We identified 41 EOAD patients (18 amnestic, 14 with LPA, and 9 with PCA) with CSF and brain MRI data. Semiquantitative ratings were used to assess medial temporal lobe atrophy and PCA, which were compared to CSF biomarker indices. Results: Lower CSF tau levels were...
Journal Articles
Dement Geriatr Cogn Disord (2017) 43 (3-4): 119–127.
Published Online: 01 February 2017
... and the A allele of rs1277306 (Table 7 ). Table 7 Multivariable logistic regression analysis for the rs1713985 and rs1277306 interaction model Alzheimer diseases Biomarkers Cognitive aging Cognitive function Cognitive impairment Mini-Mental State Examination Neurodegeneration The RE1...
Journal Articles
Franc Llorens, André Karch, Ewa Golanska, Matthias Schmitz, Peter Lange, Beata Sikorska, Pawel P. Liberski, Inga Zerr
Dement Geriatr Cogn Disord (2017) 43 (1-2): 71–80.
Published Online: 06 January 2017
...Franc Llorens; André Karch; Ewa Golanska; Matthias Schmitz; Peter Lange; Beata Sikorska; Pawel P. Liberski; Inga Zerr Background: Several biomarkers have been proposed to discriminate sporadic Creutzfeldt-Jakob disease (sCJD) from other dementias and control cases. However, their clinical accuracy...
Journal Articles
Welmoed A. Krudop, Annemiek Dols, Cora J. Kerssens, Niels D. Prins, Christiane Möller, Sigfried Schouws, Frederik Barkhof, Bart N.M. van Berckel, Charlotte E. Teunissen, Wiesje M. van der Flier, Philip Scheltens, Sietske A.M. Sikkes, Max L. Stek, Yolande A.L. Pijnenburg
Dement Geriatr Cogn Disord (2016) 41 (1-2): 16–26.
Published Online: 17 October 2015
... for behavioral variant frontotemporal dementia (bvFTD) incorporate MRI and [ 18 F]-FDG-PET. Cerebrospinal fluid (CSF) analysis is merely advised for excluding Alzheimer's disease. Aims: We aimed to assess the impact of biomarkers on diagnostic certainty and contingent changes of bvFTD diagnosis within...
Journal Articles
Dement Geriatr Cogn Disord (2015) 40 (1-2): 54–62.
Published Online: 13 May 2015
...Nina Rostgaard; Gunhild Waldemar; Jørgen Erik Nielsen; Anja Hviid Simonsen As dementia is a fast-growing health care problem, it is becoming an increasingly urgent need to provide an early diagnosis in order to offer patients the best medical treatment and care. Validated biomarkers which reflect...
Journal Articles
Anna Kämäläinen, Sanna-Kaisa Herukka, Päivi Hartikainen, Seppo Helisalmi, Virpi Moilanen, Anna Knuuttila, Lilja Jansson, Pentti J. Tienari, Anne M. Remes
Dement Geriatr Cogn Disord (2015) 39 (5-6): 287–293.
Published Online: 13 March 2015
... (ALS). The C9ORF72 expansion is associated with TDP-43 and p62 neuropathology, and amyloid plaques and neurofibrillary tangles are not common in patients with the C9ORF72 expansion. Therefore, we hypothesized that cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease [AD; Aβ 1-42 , total tau (T...
Journal Articles
Edmond Teng, Nicole Chow, Kristy S. Hwang, Paul M. Thompson, Karen H. Gylys, Gregory M. Cole, Clifford R. Jack Jr., Leslie M. Shaw, John Q. Trojanowski, Holly D. Soares, Michael W. Weiner, Liana G. Apostolova, for the Alzheimer''s Disease Neuroimaging Initiative
Dement Geriatr Cogn Disord (2015) 39 (3-4): 154–166.
Published Online: 24 December 2014
... Pittsburgh Compound B retention. In this high-risk group, plasma ApoE levels may represent a peripheral marker of underlying AD neuropathology in nondemented elderly individuals. Alzheimerߣs disease Mild cognitive impairment Magnetic resonance imaging Hippocampus Biomarkers ADNI Apolipoprotein E...
Journal Articles
Angelique Egberts, Eline H.A. Wijnbeld, Durk Fekkes, Milly A. van der Ploeg, Gijsbertus Ziere, Herbert Hooijkaas, Tischa J.M. van der Cammen, Francesco U.S. Mattace-Raso
Dement Geriatr Cogn Disord (2015) 39 (1-2): 116–124.
Published Online: 19 November 2014
...Angelique Egberts; Eline H.A. Wijnbeld; Durk Fekkes; Milly A. van der Ploeg; Gijsbertus Ziere; Herbert Hooijkaas; Tischa J.M. van der Cammen; Francesco U.S. Mattace-Raso Background/Aims: The diagnosis of delirium is not supported by specific biomarkers. In a previous study, high neopterin levels...
1